Baxter stock (NYSE: BAX), a healthcare company, has seen its stock decline by 14% over the past month. This drop followed a disappointing earnings report where the company also reduced its full-year ...

Is BAX a good stock to buy? We came across a bullish thesis on Baxter International Inc. on Heavy Moat Investments’s Substack ...

With a TTM operating cash flow of $1.25 billion, Baxter International Inc. (NYSE:BAX) is included among the 12 Cash-Rich Stocks to Buy Right Now. On May 28, Citi analyst Joanne Wuensch downgraded ...

Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large-cap stocks, released its Parnassus Value Equity Fund second-quarter 2025 investor ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Bax inhibitor 1 (BI-1) was originally discovered as an inhibitor of Bax-induced apoptosis; this review highlights the fundamental importance of BI-1 in a wider context, including in tissue homeostasis ...

Apoptosis, or programmed cell death, is a genetically regulated cellular suicide mechanism essential for multicellular organisms to remove damaged or unwanted cells and maintain tissue homeostasis ...

Investors looking for stocks in the Medical - Products sector might want to consider either Baxter International (BAX) or LeMaitre Vascular (LMAT). But which of these two companies is the best option ...

We believe Stryker stock (NYSE: SYK) is a better pick in the Medical Devices industry than Baxter stock (NYSE: BAX), given its better prospects. Although SYK trades at a superior valuation of 5.5x ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.